R.B. Credo
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Papers in
-
- Cancer therapeutics and mechanisms 3
- DNA Repair Mechanisms 2
-
- Blood properties and coagulation 5
- Co-authors
- L. Lóránd (9 shared papers)C G Curtis (6 shared papers)A. G�ray (3 shared papers)Hing L. Sham (7 shared papers)P. Stenberg (3 shared papers)Todd J. Janus (2 shared papers)Koshonna Brown (2 shared papers)Gerald E. Siefring (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (3 papers)Biochemistry (3 papers)Annals of the New York Academy of Sciences (1 paper)The Journal of Cell Biology (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
R.B. Credo
18 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 87
- Hematology 310
- Immunology and Allergy 140
- Pulmonary and Respiratory Medicine 515
- Organic Chemistry 464
- Cell Biology 134
Countries citing papers authored by R.B. Credo
This map shows the geographic impact of R.B. Credo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.B. Credo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.B. Credo more than expected).
Fields of papers citing papers by R.B. Credo
This network shows the impact of papers produced by R.B. Credo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.B. Credo. The network helps show where R.B. Credo may publish in the future.
Co-authors
The 25 scholars most cited alongside R.B. Credo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 389 | |
| 2 | 1980 | 164 | |
| 3 | 1974 | 157 | |
| 4 | 1981 | 109 | |
| 5 | 1974 | 90 | |
| 6 | 1978 | 81 | |
| 7 | 1981 | 71 | |
| 8 | 1979 | 66 | |
| 9 | 2001 | 49 | |
| 10 | 1975 | 47 | |
| 11 | 2000 | 46 | |
| 12 | Biological activity of A-289099: an orally active tubulin-binding indolyloxazoline derivative. | 2003 | 37 |
| 13 | 2007 | 33 | |
| 14 | 2006 | 29 | |
| 15 | 2001 | 19 | |
| 16 | 1995 | 7 | |
| 17 | 1992 | 6 | |
| 18 | 1983 | 5 |
About R.B. Credo
R.B. Credo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Hematology and Cell Biology, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Blood properties and coagulation (5 papers), Erythrocyte Function and Pathophysiology (4 papers), Cancer-related Molecular Pathways (3 papers), Cancer therapeutics and mechanisms (3 papers), Hemoglobin structure and function (3 papers), DNA Repair Mechanisms (2 papers), Click Chemistry and Applications (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Hematology (310 citations), Immunology and Allergy (140 citations), Pulmonary and Respiratory Medicine (515 citations), Organic Chemistry (464 citations) and Cell Biology (134 citations). R.B. Credo has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include L. Lóránd, C G Curtis, A. G�ray, Hing L. Sham, P. Stenberg, Todd J. Janus, Koshonna Brown, Gerald E. Siefring, János Molnár and David J. Frost. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Biochemistry, Annals of the New York Academy of Sciences, The Journal of Cell Biology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.